5 Stocks To Watch For April 7, 2020

Some of the stocks that may grab investor focus today are:

  • Wall Street expects Greenbrier Companies Inc GBX to report quarterly earnings at $0.29 per share on revenue of $798.97 million before the opening bell. Greenbrier shares fell 1.8% to $14.10 in pre-market trading.
  • Inovio Pharmaceuticals Inc INO disclosed that the United States FDA accepted the New Drug Application for INO-4800, a vaccine that is designed to prevent COVID-19, clearing the way for Phase 1 clinical testing in healthy volunteers. Inovio Pharmaceuticals shares gained 3.2% to $8.71 in the pre-market trading session.
  • Luminex Corporation LMNX disclosed that it received FDA emergency use authorization for ARIES SARS-CoV-2 assay to detect virus responsible for COVID-19 disease. The company issued strong Q1 sales forecast. Luminex shares climbed 8.2% to $29.30 in the pre-market trading session.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Choosing the best broker is an important part of being a successful trader or investor

  • Analysts are expecting Levi Strauss & Co. LEVI to have earned $0.35 per share on revenue of $1.47 billion in the latest quarter. Levi Strauss will release earnings after the markets close. Levi Strauss shares gained 1% to $11.05 in pre-market trading.
  • President Donald Trump's administration and 3M Co. MMM reported a deal to increase mask supply in the US. As part of the agreement, 3M will import 166.5 million masks from its China manufacturing facilities by June. 3M shares surged 4.1% to $146.50 in the pre-market trading session.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Posted In: EarningsNewsPre-Market OutlookMarketsTrading IdeasHealth CareLife Sciences Tools & ServicesStocks To WatchStocks to Watch
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!